Area Sales Manager

1Cell.Ai Inc.; Chennai District; On-site; INR 900,000 - 1,400,000; Full time

Job summary

1Cell.Ai Inc. is seeking an Area Sales Manager to drive oncogenomics adoption in Tamilnadu.

The role focuses on direct engagement with oncologists, hemato-oncologists, and pathologists to grow territory revenue through genomic/molecular oncology tests such as companion diagnostics and biomarker panels. The candidate will manage relationships with cancer centers, achieve sales targets, and represent the company at oncology conferences and CME events.

Qualifications

• 3–6+ years of specialty sales experience in oncology, oncogenomics, molecular diagnostics, or precision oncology testing.
• Existing relationships with oncologists/hemato-oncologists in Tamilnadu preferred.
• Working knowledge of genomic/biomarker testing concepts (NGS, PCR-based panels, liquid biopsy) optional.
• Proven track record of achieving sales targets in a specialty/clinical selling environment.

Responsibilities

• Drive sales of oncogenomics/molecular oncology tests within the assigned territory.
• Build and maintain relationships with oncologists, hemato-oncologists, pathologists, and cancer centers.
• Achieve monthly/quarterly sales targets and territory growth objectives.
• Conduct scientific detailing on genomic testing with treating physicians.
• Coordinate with sample logistics, CX, and lab operations teams for smooth order-to-report turnaround.
• Track competitor activity, emerging biomarker trends, and physician feedback; report to management.
• Represent the company at oncology conferences, tumor boards, and CME events.

Skills

Oncology sales

Relationship building

Clinical detailing

Target achievement

Travel willingness

Education

Bachelor's degree

Tools

NGS

PCR panels

Job description

1Cell.Ai is a precision oncology diagnostics company headquartered in Mumbai, with operations across India, amd US. The company develops advanced liquid biopsy and molecular diagnostics solutions, underpinned by proprietary R&D in ctDNA and methylation-based cancer detection technologies.

Role Summary

We are looking for an Area Sales Manager to drive our oncogenomics business across the Tamilnadu market. This is an individual contributor role focused on direct engagement with oncologists, hemato-oncologists, and pathologists — driving adoption of genomic/molecular oncology tests (e.g., companion diagnostics, biomarker testing, liquid biopsy, tumor profiling) and growing territory revenue.

Key Responsibilities

• Drive sales of oncogenomics/molecular oncology tests within the assigned territory
• Build and maintain relationships with oncologists, hemato-oncologists, pathologists, and cancer centers
• Achieve monthly/quarterly sales targets and territory growth objectives
• Conduct scientific detailing on genomic testing (biomarkers, mutation panels, liquid biopsy) with treating physicians
• Coordinate with sample logistics, CX, and lab operations teams for smooth order-to-report turnaround
• Track competitor activity, emerging biomarker trends, and physician feedback; report regularly to management
• Represent the company at oncology conferences, tumor boards, and CME events

Requirements

• [3–6]+ years of specialty sales experience in oncology, oncogenomics, molecular diagnostics, or precision oncology testing
• Existing relationships with oncologists/onco-physicians / onco surgeons / hemato-oncologists in Tamilnadu area strongly preferred
• Working knowledge of genomic/biomarker testing concepts (NGS, PCR-based panels, liquid biopsy) — ability to hold scientific conversations with clinicians - Not Mandatory
• Proven track record of achieving sales targets in a specialty/clinical selling environment
• Willingness to travel within the territory for clinicans visits
• Bachelor's degree required; science/pharmacy/life sciences background preferred (biotechnology/genetics background a plus)

What We Offer

• Opportunity to work with a fast-growing precision oncology diagnostics company at the forefront of genomic testing
• Territory ownership with direct impact on precision oncology adoption